Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

NEW YORK--(BUSINESS WIRE)--UiPath, Inc. announces Maestro Case, a new AI-native UiPath agentic case management capability.

The mean of analysts' price targets for UiPath (PATH) points to a 25.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

PATH is growing its base of high-value customers, signaling deeper enterprise adoption of its automation and AI platform.

PATH's term licensing/per-seat SaaS model avoids unpredictable AI token costs while providing deterministic orchestration that complements the growing Agentic AI use. Combined with the expanded ecosystem partnership and the forward-deployed engineering program, it is unsurprising that the company has reported accelerated backlog growth. FQ1'27 brings forth PATH's ARR growth to $1.9B (+12.2% YoY), expanded operating margins to 22%, and first-ever Q1 GAAP profitability, with it supporting the raised FY2027 guidance.

UiPath is delivering accelerating revenue growth and rising ARR, benefiting from the broader AI-driven business transformation. Despite a strong Q1 beat-and-raise, PATH shares remain down ~30% YTD, creating a compelling entry point. PATH's ARR nears $2 billion, outpacing full-year revenue guidance and providing strong demand visibility.

UiPath (PATH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.